Clinical Trials
3 trialsNCT06204614 2026-05-18
Drug Screening Using IMD in Bladder Cancer
Brigham and Women's Hospital
Phase EARLY_PHASE1 Enrolling by invitation
NCT07218003 2026-05-04
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Phase 1 Enrolling by invitation
NCT05745233 2023-08-24
Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites
China Medical University Hospital
Phase NA Enrolling by invitation